|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
391,541,000 |
Market
Cap: |
N/A |
Last
Volume: |
14,763,294 |
Avg
Vol: |
6,903,207 |
52
Week Range: |
$70.3 - $70.3 |
|
Level
I Sector: |
Consumer Discretionary |
Level
II Sector: |
Retail |
Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Driscoll John Patrick |
President - New Markets |
|
2011-02-22 |
4 |
D |
$61.45 |
$338,036 |
D/D |
(5,501) |
92,538 |
|
- |
|
Smith Jack Allen |
SVP, Chief Marketing Officer |
|
2011-02-22 |
4 |
D |
$61.45 |
$185,518 |
D/D |
(3,019) |
75,707 |
|
- |
|
Stettin Glen D. |
Chief Medical Officer |
|
2011-02-22 |
4 |
D |
$61.45 |
$98,504 |
D/D |
(1,603) |
28,419 |
|
- |
|
Klepper Kenneth O |
President-Chief Oper. Officer |
|
2011-02-22 |
4 |
D |
$61.45 |
$664,213 |
D/D |
(10,809) |
177,092 |
|
- |
|
Moriarty Thomas M |
Genl Counsel & Secretary, SVP |
|
2011-02-22 |
4 |
D |
$61.45 |
$369,192 |
D/D |
(6,008) |
61,259 |
|
- |
|
Taylor Glenn C |
Group President, Key Accounts |
|
2011-02-22 |
4 |
D |
$61.45 |
$292,502 |
D/D |
(4,760) |
101,070 |
|
- |
|
Fitzpatrick Steven R |
Pres, Accredo Health, Inc. |
|
2011-02-22 |
4 |
D |
$61.45 |
$19,050 |
D/D |
(310) |
80,061 |
|
- |
|
Snow David B Jr |
Chairman and CEO |
|
2011-02-22 |
4 |
D |
$61.45 |
$1,027,936 |
D/D |
(16,728) |
207,476 |
|
- |
|
Griffin Brian T |
CEO, Medco Celesio BV |
|
2011-02-22 |
4 |
D |
$61.45 |
$429,843 |
D/D |
(6,995) |
92,354 |
|
- |
|
Kornwasser Laizer |
SVP-Retail, Mail & Diabetes |
|
2011-02-22 |
4 |
D |
$61.45 |
$251,576 |
D/D |
(4,094) |
58,525 |
|
- |
|
Princivalle Karin |
SVP, Human Resources |
|
2011-02-22 |
4 |
D |
$61.45 |
$173,658 |
D/D |
(2,826) |
41,330 |
|
- |
|
Klepper Kenneth O |
President-Chief Oper. Officer |
|
2011-01-13 |
4 |
AS |
$65.00 |
$9,680,970 |
D/D |
(148,938) |
187,901 |
|
- |
|
Klepper Kenneth O |
President-Chief Oper. Officer |
|
2011-01-13 |
4 |
OE |
$29.24 |
$3,578,976 |
D/D |
122,400 |
336,839 |
|
- |
|
Griffin Brian T |
CEO, Medco Celesio BV |
|
2011-01-13 |
4 |
AS |
$65.00 |
$13,413,270 |
D/D |
(206,358) |
99,349 |
|
- |
|
Griffin Brian T |
CEO, Medco Celesio BV |
|
2011-01-13 |
4 |
OE |
$22.10 |
$6,890,166 |
D/D |
206,358 |
305,707 |
|
- |
|
Moriarty Thomas M |
Genl Counsel & Secretary, SVP |
|
2011-01-04 |
4 |
D |
$61.27 |
$246,796 |
D/D |
(4,028) |
67,267 |
|
- |
|
Epstein Robert S |
Pres, Adv. Clinical Science |
|
2011-01-04 |
4 |
D |
$61.27 |
$738,732 |
D/D |
(12,057) |
118,841 |
|
- |
|
Wilson Blenda J |
Director |
|
2011-01-03 |
4 |
AS |
$61.27 |
$214,445 |
D/D |
(3,500) |
28,900 |
|
- |
|
Wilson Blenda J |
Director |
|
2011-01-03 |
4 |
OE |
$26.02 |
$91,053 |
D/D |
3,500 |
32,400 |
|
- |
|
Griffin Brian T |
CEO, Medco Celesio BV |
|
2010-12-01 |
4 |
AS |
$62.00 |
$1,060,882 |
D/D |
(17,111) |
99,349 |
|
- |
|
Moriarty Thomas M |
Genl Counsel & Secretary, SVP |
|
2010-12-01 |
4 |
AS |
$61.75 |
$298,129 |
D/D |
(4,828) |
71,295 |
|
- |
|
Moriarty Thomas M |
Genl Counsel & Secretary, SVP |
|
2010-11-30 |
4 |
D |
$61.32 |
$255,827 |
D/D |
(4,172) |
76,123 |
|
- |
|
Moriarty Thomas M |
Genl Counsel & Secretary, SVP |
|
2010-11-22 |
4 |
AS |
$61.00 |
$2,054,358 |
D/D |
(33,678) |
80,295 |
|
- |
|
Moriarty Thomas M |
Genl Counsel & Secretary, SVP |
|
2010-11-22 |
4 |
OE |
$40.58 |
$1,366,653 |
D/D |
33,678 |
113,973 |
|
- |
|
Stettin Glen D. |
Chief Medical OfficerOfficer |
|
2010-11-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
30,021 |
|
- |
|
672 Records found
|
|
Page 5 of 27 |
|
|